{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T15:25:39Z","timestamp":1764602739884,"version":"3.44.0"},"reference-count":22,"publisher":"MJS Publishing, Medical Journals Sweden AB","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Oncologica"],"published-print":{"date-parts":[[2003,3]]},"DOI":"10.1080\/02841860310005697","type":"journal-article","created":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T19:11:50Z","timestamp":1083438710000},"page":"147-153","source":"Crossref","is-referenced-by-count":20,"title":["Biodistribution and Pharmacokinetics of<sup>111<\/sup>In-DTPA-Labelled Pegylated Liposomes After Intraperitoneal Injection"],"prefix":"10.2340","volume":"42","author":[{"given":"Konstantinos N.","family":"Syrigos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard G.","family":"Vile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Michael","family":"Peters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin J.","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1183","published-online":{"date-parts":[[2011,5,5]]},"reference":[{"key":"CIT0001","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1056\/NEJM199612263352603","volume":"335","author":"Alberts DS","year":"1996","journal-title":"N Engl J Med"},{"key":"CIT0002","first-page":"127","volume":"42","author":"Buchsbaum Hi","year":"1975","journal-title":"Natl Cancer Inst Monogr"},{"key":"CIT0003","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1200\/JCO.1997.15.11.3399","volume":"15","author":"Edwards RP","year":"1997","journal-title":"J Clin Oncol"},{"key":"CIT0004","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/bjc.1993.349","volume":"68","author":"Hird V. Maraveyas A, Snook D. et al.","year":"1993","journal-title":"Br J Cancer"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1126\/science.7871422"},{"key":"CIT0008","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1517\/13543784.10.6.1045","volume":"10","author":"Harrington KJ","year":"2001","journal-title":"Expert Opin Invest Drugs"},{"key":"CIT0009","first-page":"1556","volume":"87","author":"Madhavan S. Northfelt","year":"1995","journal-title":"Lack of vesicant injury follow-ing extravasationliposomal doxorubicin. J Nail CancerInst"},{"key":"CIT0010","first-page":"2528","volume":"6","author":"Harrington KJ","year":"2000","journal-title":"Clin Cancer Res"},{"key":"CIT0011","first-page":"1536","volume":"29","author":"Gonda] JA","year":"1993","journal-title":"Comparative pharmacological, toxicological and antitumoural evaluation of free and liposome-encapsulated cisplatin in rodents. Eur J Cancer"},{"key":"CIT0012","first-page":"103","volume":"71","author":"Sharma A","year":"1997","journal-title":"et al. Activity of paclitaxel liposome formulations against human ovarian tumour xeno-grafts. Int J Cancer"},{"key":"CIT0013","first-page":"265","volume":"107","author":"Sharma A","year":"1996","journal-title":"Paclitaxel-lipo-somes for intracavitary therapy of intraperitoneal P388 leukaemia. Cancer Lett"},{"key":"CIT0014","first-page":"3671","volume":"72","author":"Vaage J. Donovan","year":"1993","journal-title":"Mayhew E. Abra R. Huang A. Ther-apy of human ovarian carcinoma xenografts using doxoru-bicin encapsulated in sterically stabilised liposomes. Cancer"},{"key":"CIT0015","first-page":"365","volume":"30","author":"Vadiei K","year":"1992","journal-title":"Sampedro F, Perez-Soler R. Pharmacokinetics of liposome-entrapped cis-bis-neodecanoato trans-R. R-1,2 diaminocyclohexane plat-Mum (II) and cisplatin given i.v. and i.p. in the rat. Cancer Chemother Pharmacol"},{"key":"CIT0016","first-page":"499","volume":"4","author":"Cabanes A","year":"1998","journal-title":"Comparative study of the antitumour activity of free doxoru-bicin and polyethylene glycol-coated liposomal doxorubicin in a mouse lymphoma model. Clin Cancer Res"},{"key":"CIT0017","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/0002-9378(89)90296-2","volume":"160","author":"Delgado G","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"CIT0018","first-page":"373","volume":"3","author":"Perez-Soler R","year":"1997","journal-title":"Phase I clinical and pharmacological study of liposome-entrapped NDDP administered intrapleurally in patients with malignant pleural effusions. Clin Cancer Res"},{"key":"CIT0019","first-page":"232","volume":"83","author":"Harrington KJ","year":"2000","journal-title":"13iodistribution and pharmacokinet-ics of \"In-DTPA-labelled pegylated Iiposornes in a human tumour xenograft model: implications for novel targeting strategies. Br J Cancer"},{"key":"CIT0020","first-page":"243","volume":"7","author":"Harrington KJ","year":"2001","journal-title":"Effective targeting of solid tumors in patients with locally advanced cancers by radiola-beled pegylated liposomes. Clin Cancer Res"},{"key":"CIT0021","first-page":"253","volume":"31","author":"O'Dwyer PJ","year":"1991","journal-title":"Pharmacologic study of etoposide and cis-plaint by the intraperitoneal route. J Clin Pharmacol"},{"issue":"185","key":"CIT0022","first-page":"8","volume":"36","author":"Malviya VK","year":"1990","journal-title":"Gynecol Oncol"},{"key":"CIT0023","first-page":"987","volume":"15","author":"Muggia FM","year":"1997","journal-title":"et at. Phase 11 study of liposomal doxorubicin in refractory ovarian cancer: antitu-mour activity and toxicity modification by liposomal encapsu-lation. J Cliii Oncol"},{"key":"CIT0024","first-page":"369","volume":"78","author":"Markman M","year":"2000","journal-title":"Belinson J. Phase 2 trial of liposomal doxorubicin (40 mg\/m2) in platinumipaclitaxel-refractory ovarian and fallopian tube cancers and primary carcinoma of the peritoneum. Gynecol Oncol"}],"container-title":["Acta Oncologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/02841860310005697","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T18:04:58Z","timestamp":1756404298000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actaoncologica\/article\/view\/26804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3]]},"references-count":22,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2011,5,4]]},"published-print":{"date-parts":[[2003,3]]}},"alternative-id":["10.1080\/02841860310005697"],"URL":"https:\/\/doi.org\/10.1080\/02841860310005697","relation":{},"ISSN":["0284-186X","1651-226X"],"issn-type":[{"type":"print","value":"0284-186X"},{"type":"electronic","value":"1651-226X"}],"subject":[],"published":{"date-parts":[[2003,3]]}}}